P&T
Our
Other
Journal
MediMedia Managed Markets

 

 

July 1998

Everyone involved seems to be grappling with ethical issues arising from the Human Genome Program. The science is still in flux.
MARTIN KOHL
What's a doctor to do when her patients embrace the untried and outlandish — sometimes with their insurers' blessings?
Doreen R. Orion, M.D.
HMOs can miss the mark for a lot of reasons. But health care experts say it's difficult to pin a scarlet letter on a health plan.
Frank Diamond ; Michael D. Dalzell
Medicare beneficiaries could gain a lot from managed care, and so could health plans. But it's not all that easy.
Peter Wehrwein
FACCT's president talks about the need for patients to take charge of their health care and the challenges of developing a set of quality measures for children.



Departments
Washington Initiatives